Connection

KARL-DIMITER BISSIG to Carcinoma, Hepatocellular

This is a "connection" page, showing publications KARL-DIMITER BISSIG has written about Carcinoma, Hepatocellular.
  1. Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model. J Hepatol. 2024 02; 80(2):282-292.
    View in: PubMed
    Score: 0.119
  2. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
    View in: PubMed
    Score: 0.079
  3. The camKK2/camKIV relay is an essential regulator of hepatic cancer. Hepatology. 2015 Aug; 62(2):505-20.
    View in: PubMed
    Score: 0.066
  4. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.